About Us

CPeRT, based in the CCEB and led by Dr. Sean Hennessy, was established in 2012 to improve public health and advance science by conducting leading-edge, interdisciplinary research in pharmacoepidemiology, and to train the next generation of research leaders in pharmacoepidemiology. Despite CPeRT’s recent establishment, Penn investigators have been leaders in pharmacoepidemiology since the field’s inception in the early 1980s.

CPeRT includes nearly 100 investigators (Penn faculty engaged in pharmacoepidemiology research), adjunct investigators (whose primary affiliation is outside of Penn), and Investigators-in-Training. CPeRT helps to lead Penn’s MSCE- and PhD-granting pharmacoepidemiology training programs, hosts a weekly Pharmacoepidemiology Rounds series, hosts a monthly Research-in-Progress series, hosts visiting pharmacoepidemiology methodologists, maintains phamacoepidemiologic research databases, and funds pilot projects. CPeRT members are leaders in the development, evaluation and application of new methods to study the health effects of medications in populations. CPeRT houses the American editorial office of the journal Pharmacoepidemiology and Drug Safety. CPeRT members also edit the books Pharmacoepidemiology and Textbook of Pharmacoepidemiology.

  CPeRT members develop real-world evidence about the health effects of medications and other medical products, and prepare the next generation of pharmacoepidemiology leaders. CPeRT is an academic partner to the Food and Drug Administration (FDA)-funded Sentinel Initiative. CPeRT members are also editors of the journal Pharmacoepidemiology and Drug Safety, and the books Pharmacoepidemiology, 6th edition and Textbook of Pharmacoepidemiology, 3rd edition.   


8th Floor, Blockley Hall

University of Pennsylvania

423 Guardian Drive

Philadelphia, PA 19104-6021